German Exhibition Health (000813): Progress In Signing Investment Letter Of Intent

Limited by Share Ltd announcements on progress of investment letter of intent

All members of the company and its board of Directors ensure that the contents of the information disclosure are authentic, accurate and complete, without false records, misleading statements or major omissions.

I. signing of letter of intent

In September 24, 2019, the company and Beijing Changjiang Mai Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Yangtze River pulse company", "the target company") and its major shareholder Dai Yanzhen made preliminary contact with the company's Beijing Changjiang Mai Pharmaceutical Technology Co., Ltd., and reached the intent clause. On the same day, they signed the investment letter of intent of the German exhibition great health Limited by Share Ltd and Dai Yanzhen and Beijing Changjiang medical science and technology limited liability company (hereinafter referred to as the "letter of intent"). For details, see the announcement of the company's signing of the letter of intent for investment (2019-049) on September 25, 2019.

Two. Progress of the letter of intent

The validity of the letter of intent is three months from the date of entry into force of the letter of intent. The company has conducted the audit, audit and evaluation of the target company, but the work has not yet been completed. In order to continue to promote cooperation, the two sides agreed to sign a supplementary agreement on the letter of intent for investment between the German exhibition great health Limited by Share Ltd and Dai Yanzhen and Beijing Changjiang Mai Pharmaceutical Technology Co., Ltd.. The main contents are as follows:

Party A: Germany exhibition great health Limited by Share Ltd (hereinafter referred to as "Germany exhibition health")

Party B: Dai Yanzhen

Beijing Changjiang Mai Pharmaceutical Technology Co., Ltd.

(1) duration of cooperation

1, the parties agreed to extend the original term of cooperation for three months, counting from the date when the supplementary agreement came into effect. The duration of such cooperation can be expired or extended on time when all parties agree.

2. If the parties have signed formal legal documents on cooperation matters within the term of cooperation stipulated by this supplementary agreement, the parties shall perform their respective obligations in accordance with the provisions of the formal legal documents.

(two) the entry into force, termination and termination of this supplementary agreement.

1. This supplementary agreement shall be effective after the parties sign and Party A performs the corresponding internal examination and approval procedures.

2. The supplementary agreement can be terminated in advance by consensus.

3. The termination of this supplementary agreement:

1) the supplementary agreement shall be terminated upon the expiration of the time limit stipulated by this supplementary agreement and the parties have not agreed to extend the agreement. 2) from the date of signing formal legal documents on cooperation matters, this supplementary agreement shall be terminated automatically.

Three. Reference documents

1. The supplementary agreement on the letter of intent for investment between Dai Yanzhen and Beijing Changjiang Mai Medical Technology Co., Ltd., "Germany exhibition great health Limited by Share Ltd".

Notice hereby.

Board of directors of Limited by Share Ltd

December 24, 2019